Un antidepresivo barato y disponible de forma genérica puede reducir el riesgo de enfermedad grave por covid-19 en casi un tercio en personas con alto riesgo, informaron investigadores el miércoles. Un ensayo entre aproximadamente 1.500 pacientes en Brasil mostró que aquellos que tomaron el medicamento, conocido como fluvoxamina, tenían menos […]
Read More
La compañía Moderna ha anunciado este lunes que datos provisionales positivos del estudio de fase 2/3 que estudia su vacuna contra la COVID-19 en niños de 6 a menos de 12 años de edad. Este análisis provisional mostró una sólida respuesta de anticuerpos neutralizantes tras dos dosis de la vacuna en dosis de 50 ug, […]
Read More
Créditos: Comité científico Covid
Read More
Americans this week were handed a big decision when it comes to getting a COVID-19 vaccine booster. The U.S. Centers for Disease Control and Prevention (CDC) on Thursday said individuals who qualify could choose a different vaccine from the one they received for their initial inoculation. For Americans asking how to […]
Read More
As the number of Americans getting COVID-19 vaccines has risen, there is a heightened push to provide booster shots to some vaccinated persons to ensure that their immunity continues. Question 1 of 8 Now that COVID-19 booster shots are available to a growing population, how likely are you to get […]
Read More
Rusia fue el primer país del mundo en registrar una vacuna contra el covid-19, la Sputnik V, y ha desarrollado con éxito otros tres inoculantes que se encuentran disponibles en el país. Apoyada en sus buenos resultados, publicados en la prestigiosa revista The Lancet, la Sputnik V fue incluso exportada a unos 70 países, entre ellos México, […]
Read More
Summary What is already known about this topic? Although deaths after COVID-19 vaccination have been reported to the Vaccine Adverse Events Reporting System, few studies have been conducted to evaluate mortality not associated with COVID-19 among vaccinated and unvaccinated groups. What is added by this report? During December 2020–July 2021, […]
Read More
Los expertos advierten de que ya representa el alrededor del 6% de los nuevos casos detectados en Reino Unido, y piden que no cunda el pánico a la espera de mayor evidencia científica. La variante Delta del SARS-CoV-2 (B.1.617.2, detectada originalmente en India) es desde hace ya tiempo la gran dominante a nivel […]
Read More
MILAN (Reuters) – People vaccinated against COVID-19 are highly unlikely to die of the disease unless very old and already badly ill before getting it, a study in Italy showed on Wednesday. The study by the national Health Institute (ISS), contained in a regular ISS report on COVID-19 deaths, found […]
Read More
Antithrombotic therapy in clinically stable, nonhospitalized COVID-19 patients does not offer protection against adverse cardiovascular or pulmonary events, new randomized clinical trial results suggest. Antithrombotic therapy has proven useful in acutely ill inpatients with COVID-19, but in this study, treatment with aspirin or apixaban (Eliquis) did not reduce the rate of all-cause mortality, symptomatic […]
Read More